As Hong Kong accelerates its transformation into a global biotech and MedTech powerhouse, BioSpectrum ...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
Could you please share some details of the company's investment plans, and new product development in the coming years?&...
What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...
Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...
Growing trends in healthcare digitalization are continuously transforming execution and practices in the ...
Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...
The value-based care model is gaining momentum in the healthcare industry, and it is not hard to see why. After al...
Accessibility to quality healthcare is commonly regarded as a fundamental human right for every person. This is outlined...
Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...
The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. In 2023, that trend wil...
What are the barriers to access that are impacting patient outcomes in managing antimicrobial resistance? Why do they ...
